Lifevantage Gross Margin 2010-2024 | LFVN

Current and historical gross margin for Lifevantage (LFVN) over the last 10 years. The current gross profit margin for Lifevantage as of March 31, 2024 is %.
Lifevantage Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-03-31 $0.21B $0.16B 79.51%
2023-12-31 $0.21B $0.17B 79.62%
2023-09-30 $0.21B $0.17B 79.34%
2023-06-30 $0.21B $0.17B 79.44%
2023-03-31 $0.21B $0.17B 80.09%
2022-12-31 $0.21B $0.17B 80.19%
2022-09-30 $0.21B $0.17B 81.46%
2022-06-30 $0.21B $0.17B 82.04%
2022-03-31 $0.21B $0.17B 81.90%
2021-12-31 $0.21B $0.18B 82.55%
2021-09-30 $0.22B $0.18B 82.65%
2021-06-30 $0.22B $0.18B 82.35%
2021-03-31 $0.23B $0.19B 83.11%
2020-12-31 $0.23B $0.19B 83.41%
2020-09-30 $0.23B $0.19B 83.55%
2020-06-30 $0.23B $0.20B 84.05%
2020-03-31 $0.23B $0.19B 83.41%
2019-12-31 $0.23B $0.19B 83.41%
2019-09-30 $0.23B $0.19B 83.19%
2019-06-30 $0.23B $0.19B 82.74%
2019-03-31 $0.22B $0.19B 83.48%
2018-12-31 $0.22B $0.18B 83.11%
2018-09-30 $0.21B $0.17B 82.86%
2018-06-30 $0.20B $0.17B 82.76%
2018-03-31 $0.20B $0.16B 82.00%
2017-12-31 $0.19B $0.16B 81.96%
2017-09-30 $0.19B $0.16B 82.47%
2017-06-30 $0.20B $0.17B 83.00%
2017-03-31 $0.20B $0.17B 83.17%
2016-12-31 $0.21B $0.18B 83.10%
2016-09-30 $0.22B $0.18B 83.33%
2016-06-30 $0.21B $0.17B 83.50%
2016-03-31 $0.20B $0.17B 83.84%
2015-12-31 $0.19B $0.16B 84.49%
2015-09-30 $0.18B $0.16B 84.70%
2015-06-30 $0.19B $0.16B 85.79%
2015-03-31 $0.20B $0.17B 85.57%
2014-12-31 $0.21B $0.18B 85.78%
2014-09-30 $0.22B $0.18B 85.58%
2014-06-30 $0.21B $0.18B 85.05%
2014-03-31 $0.21B $0.18B 85.24%
2013-12-31 $0.21B $0.18B 85.85%
2013-09-30 $0.21B $0.17B 83.01%
2013-06-30 $0.21B $0.17B 82.69%
2013-03-31 $0.20B $0.17B 82.59%
2012-12-31 $0.19B $0.15B 81.82%
2012-09-30 $0.16B $0.14B 85.53%
2012-06-30 $0.13B $0.11B 85.71%
2012-03-31 $0.10B $0.08B 86.46%
2011-12-31 $0.07B $0.06B 85.71%
2011-09-30 $0.05B $0.04B 84.62%
2011-06-30 $0.04B $0.03B 84.21%
2011-03-31 $0.03B $0.02B 85.19%
2010-12-31 $0.02B $0.02B 85.00%
2010-09-30 $0.02B $0.01B 86.67%
2010-06-30 $0.01B $0.01B 90.91%
2010-03-31 $0.01B $0.01B 77.78%
2009-12-31 $0.01B $0.01B 85.71%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.096B $0.213B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.887B 20.45
Becton Dickinson (BDX) United States $66.122B 18.71
West Pharmaceutical Services (WST) United States $24.159B 43.30
Cardinal Health (CAH) United States $23.477B 13.43
Align Technology (ALGN) United States $19.244B 37.15
Cooper (COO) United States $18.860B 28.54
Labcorp (LH) United States $16.830B 14.49
Henry Schein (HSIC) United States $9.184B 16.34
DENTSPLY SIRONA (XRAY) United States $5.702B 14.76
Merit Medical Systems (MMSI) United States $4.760B 26.09
CONMED (CNMD) United States $2.281B 20.69
Patterson (PDCO) United States $2.145B 10.27
STAAR Surgical (STAA) United States $2.022B 77.66
Atrion (ATRI) United States $0.815B 43.51
Pro-Dex (PDEX) United States $0.067B 34.03
Biolase (BIOL) United States $0.006B 0.00